DLG4 Gene (PSD-95): Synaptic Scaffolding Protein and Its Role in Neurodevelopmental Disorders

Comprehensive genetic and functional annotation of DLG4, encoding postsynaptic density protein 95 (PSD-95), a key regulator of synaptic plasticity and a candidate gene for intellectual disability and schizophrenia.

Gene Information Card

Symbol DLG4
Full Name Discs Large Homolog 4 (Drosophila)
Gene Type Protein coding
Chromosomal Location 17p13.1
NCBI Gene ID 1742 ncbi.nlm.nih.gov/gene/1742
Ensembl ID ENSG00000132535
UniProt ID P78352
OMIM ID 602887
HGNC ID 2903
Aliases PSD95, SAP90, FLJ97752, DLG4

Description

The DLG4 gene encodes postsynaptic density protein 95 (PSD-95), a member of the membrane-associated guanylate kinase (MAGUK) family. PSD-95 is a critical scaffolding protein localized at excitatory glutamatergic synapses, where it organizes neurotransmitter receptors (e.g., NMDA and AMPA receptors), ion channels, and signaling molecules. It plays a central role in synaptic maturation, plasticity, and learning. De novo loss-of-function mutations in DLG4 are associated with a neurodevelopmental disorder characterized by intellectual disability, developmental delay, and behavioral abnormalities. The protein contains three PDZ domains, an SH3 domain, and a guanylate kinase (GK) domain, which mediate its interactions with a wide array of synaptic proteins.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Intellectual Developmental Disorder 62 (MRD62) Haploinsufficiency due to de novo loss-of-function mutations (nonsense, frameshift, splice-site) leading to reduced PSD-95 protein levels and disrupted synaptic scaffolding. ClinVar; OMIM #618793; PMID: 30323198
Schizophrenia Common genetic variants and rare copy number variations in DLG4 may alter PSD-95 expression, affecting glutamatergic signaling and synaptic connectivity in the prefrontal cortex. GWAS; PMID: 25056061; PMID: 28138101
Autism Spectrum Disorder (ASD) Rare de novo missense and loss-of-function variants identified in ASD cohorts, suggesting a role in synaptic dysfunction underlying ASD pathophysiology. SFARI Gene; PMID: 29276005
Major Depressive Disorder (MDD) Altered DLG4 expression and PSD-95 protein levels in the prefrontal cortex of MDD patients, potentially contributing to synaptic atrophy. PMID: 26001636

Expression Profile

Tissue Expression
Tissue nTPM level
Cerebral Cortex 127.5 High
Hippocampus 118.3 High
Cerebellum 85.2 High
Basal Ganglia 62.1 Medium
Spinal Cord 45.8 Medium
Testis 12.4 Low
Liver 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (Neuroblastoma) 78.5 High expression; used as neuronal model
SK-N-AS (Neuroblastoma) 65.3 Moderate expression
U-87 MG (Glioblastoma) 42.1 Moderate expression
HEK293 (Embryonic Kidney) 3.2 Low; often used for heterologous expression studies
HeLa (Cervical Carcinoma) 1.8 Very low; not endogenous
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.657C>A (p.Tyr219Ter) Nonsense Rare (de novo) Premature stop codon; loss-of-function; associated with MRD62
c.1129_1130del (p.Leu377ValfsTer5) Frameshift Rare (de novo) Truncated protein; loss-of-function; associated with MRD62
c.138+1G>A Splice-site Rare (de novo) Aberrant splicing; loss-of-function; associated with MRD62
c.466G>A (p.Asp156Asn) Missense Rare (de novo) Alters PDZ1 domain; likely affects ligand binding; uncertain significance
c.1901C>T (p.Pro634Leu) Missense Rare (de novo) Located in GK domain; may affect protein stability; uncertain significance
Mutation functional classification

Loss of Function (LOF)

Predominant mechanism. Nonsense, frameshift, and splice-site mutations lead to nonsense-mediated decay or truncated proteins, resulting in haploinsufficiency. This disrupts the stoichiometry of the postsynaptic density and impairs synaptic transmission and plasticity.

Gain of Function (GOF)

Not well established. No clear gain-of-function mutations have been reported for DLG4 in human disease. Some missense variants may theoretically alter protein-protein interactions, but evidence is lacking.

Dominant Negative (DN)

Possible but not confirmed. Certain missense mutations in the PDZ domains could potentially interfere with the function of the wild-type protein by forming non-functional complexes, but this has not been demonstrated in vivo.

Pathways

Glutamatergic synapse (KEGG: hsa04724)
Long-term potentiation (KEGG: hsa04720)
Long-term depression (KEGG: hsa04730)
Neuroactive ligand-receptor interaction (KEGG: hsa04080)
Postsynaptic density protein signaling (Reactome: R-HSA-6794362)

Protein Summary

PSD-95 is a 724-amino acid protein with a molecular weight of approximately 80 kDa. It contains three N-terminal PDZ domains (PDZ1-3), an SH3 domain, and a C-terminal guanylate kinase (GK) domain. PDZ1 and PDZ2 bind to the C-termini of NMDA receptor subunits (GluN2A/B) and potassium channels (Kv1.4). PDZ3 interacts with AMPA receptor auxiliary subunits (e.g., stargazin/TARPs). The SH3-GK domain forms an intramolecular interaction that regulates protein conformation. PSD-95 is palmitoylated at N-terminal cysteines (Cys3, Cys5), which is essential for its synaptic targeting and clustering. It is a core organizer of the postsynaptic density, linking receptors to the actin cytoskeleton and downstream signaling pathways (e.g., Ras/ERK, PI3K/Akt).

Related Products

Product name Cat.No. Species Gene ID
DLG4 Knockout HEK293 Cell Line EDJ-KQ1388 Human 1742 Details Get a Quote
DLG4 Knockout A-549 Cell Line EDJ-KQ20907 Human 1742 Details Get a Quote
DLG4 Knockout HCT 116 Cell Line EDJ-KQ20908 Human 1742 Details Get a Quote
DLG4 Knockout HeLa Cell Line EDJ-KQ20909 Human 1742 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: